Screener
Zevra Therapeutics, Inc. ZVRA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s prepaid & other current?
- Zevra Therapeutics, Inc. (ZVRA) reported prepaid & other current of $4.79M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s prepaid & other current changed year-over-year?
- Zevra Therapeutics, Inc.'s prepaid & other current increased by 10.2% year-over-year, from $4.35M to $4.79M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s prepaid & other current has grown at a 36.4% compound annual growth rate (CAGR), from $1.48M to $7M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Zevra Therapeutics, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude